A novel MSH2 germline mutation in a Druze HNPCC family

Familial Cancer

Volumn 7, Issue 2, 2008, Pages 135-139

  Zidan, Jamal ^a,b   Niessen, Renée C ^c   Laitman, Yael ^d   Rozeveld, Dennie ^c   Hofstra, Robert M W ^c   Friedman, Eitan ^d,e  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

DGGE; Druze faith; Germline mutations; HNPCC; Inherited predisposition to colon cancer; MSH2 gene

Indexed keywords

PROTEIN MSH2;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; COLORECTAL CANCER; DENATURING GRADIENT GEL ELECTROPHORESIS; ENDOMETRIUM CANCER; EXON; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HUMAN; MINORITY GROUP; MISMATCH REPAIR; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STOMACH CANCER;

ADOLESCENT; ADULT; ARABS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; ISRAEL; MALE; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; PEDIGREE;

EID: 45749142471     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9157-5     Document Type: Article

References (32)

1. Berends MJ, Wu Y, Sijmons RH et al (2002) Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. Am J Hum Genet 70:26-37
2. Lynch HT, Smyrk T (1996) Hereditary nonpolyposis colorectal cancer (lynch syndrome) an updated review. Cancer 78:1149-1167
3. Aaltonen LA, Salovaara R, Kristo P et al (1998) Incidence of HNPCC and the feasibility of molecular screening for the disease. N Engl J Med 338:1481-1487
4. Vasen HF, Mecklin JP, Meera-Khan P et al (1991) The international collaborative group on hereditary non-polyposis colorectal cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425
5. Vasen HF, Watson P, Mecklin JP et al (1999) New clinical criteria for HNPCC proposed by the ICG on HNPCC. Gastroenterology 116:1453-1456
6. Peltomaki P, Vasen HF (1997) Mutations predisposing to HNPCC: database and results of a collaborative study. The international collaborative group on HNPCC. Gastroenterology 113:1146-1158
7. Nicolaides NC, Papadopoulos N, Liu B et al (1994) Mutations of two PMS homologues in hereditary non polyposis colorectal cancer. Nature 371:75-80
8. Akiyama Y, Sato H, Yamada T et al (1997) Germline mutation of the MSH6/GTBP gene in an atypical hereditary non-polyposis colorectal cancer kindred. Cancer Res 57:3920-3923
9. Miyaki M, Konishi M, Tanaka K et al (1997) Germline mutation of MSH6 as the cause of hereditary non polyposis colorectal cancer. Nat Genet 17:271-272
10. Kolodner RD, Tytell JD, Schmeits JL et al (1999) Germ line MSH6 mutations in colorectal cancer families. Cancer Res 59:5068-5074
11. Wijnen J, de Leeuw W, Vasen H et al (1993) Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 23:142-144
12. Wu Y, Berends MJ, Mensink RG et al (1999) Association of hereditary non polyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 65:1291-1298
13. Wagner A, Barrows A, Wijnen JT et al (2003) Molecular analysis of hereditary non polyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletions of the MSH2 gene. Am J Hum Genet 72:1088-1100
14. Foulkes WD, Thiffault I, Gruber SB et al (2002). The founder mutation MSH2*1906G→C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet 71:1395-1412
15. Guillem JG, Moore HG, Palmer C et al (2004) A636P testing in Ashkenazi Jews. Fam Cancer 3:223-227
16. Nystrom-Lahti M, Kristo P, Nicolaides NC et al (1995) Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1:1203-1206
17. Moisio AL, Sistonen P, Weissenbach J et al (1996) Age and origin of two common MLH1 mutations predisposing to hereditary colon cancer. Am J Hum Genet 59:1243-1251
18. Lynch HT, Coronel SM, Okimoto R et al (2004) A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States. JAMA 291:718-724
19. Vardi-Saliternik R, Friedlander Y, Cohen T (2002) Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol 29:422-431
20. Gross DJ, Avishai N, Meiner V et al (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. J Clin Endocrinol Metab 81:147-149
21. Wu Y, Nystrom-Lahti M, Osinga J et al (1997) MSH2 and MLH1 mutations in sporadic replication error-positive colorectal carcinoma as assessed by two-dimensional DNA electrophoresis. Genes Chromosomes Cancer 18:269-278
22. Gille JJ, Hogervost FB, Pals G, et al (2002) Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer 87:892-897
23. Syngal S, Fox EA, Li C et al (1999) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA 282:247-253
24. Kouraklis G, Misiakos EP (2005) Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management. Dig Dis Sci 50:336-344
25. Ponz de Leon M, Benatti P, Di Gregorio C et al (2004) Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer. Br J Cancer 90:882-887
26. Wagner A, van Kessel I, Kriege MG et al (2005) Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures. Fam Cancer 4:295-300
27. Halbert CH, Lynch H, Lynch J et al (2004) Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 164:1881-1887
28. Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16:201-213
29. Watson P, Riley B (2005) The tumor spectrum in the Lynch syndrome. Fam Cancer 4:245-248
30. Park YJ, Shin KH, Park JG (2000) Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 6:2994-2998
31. Lucci-Cordisco E, Zito I, Gensini F et al (2003) Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet A 122:325-334
32. Fares F, Axelord Ran S, David M et al (2004) Identification of two mutations for ataxia telangiectasia among the Druze community. Prenat Diagn 24:358-362